Acumen pharmaceuticals to report first quarter 2022 financial results on may 16, 2022

Charlottesville, va. and carmel, ind., may 11, 2022 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for alzheimer's disease (ad), today announced that the company will report its financial results for the first quarter 2022 on monday, may 16, 2022. the company will host a conference call and live audio webcast at 4:30 p.m. et to provide a business and financial update.
ABOS Ratings Summary
ABOS Quant Ranking